Palisade Bio (PALI) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 10, 2026, to be held virtually for shareholders of record as of April 15, 2026.

• Proxy materials, including the notice, proxy statement, and annual report, are available online, with paper copies available upon request.

Voting matters and shareholder proposals

• Election of four directors to serve until the 2027 annual meeting or until successors are duly elected.

• Ratification of Baker Tilly US, LLP as independent auditor for fiscal year ending December 31, 2026.

• Approval to amend the certificate of incorporation to increase authorized common stock from 300,000,000 to 450,000,000, raising total authorized capital stock to 457,000,000.

• Approval of the Amended and Restated 2021 Equity Incentive Plan.

• Approval of the Amended and Restated 2021 Employee Stock Purchase Plan.

• Advisory vote on executive compensation (say-on-pay).

• Approval of equity award grants to non-employee directors.

Board of directors and corporate governance

• Four nominees for director positions: J.D. Finley, Donald Williams, Emil Chuang, and Robert F. Baltera, Jr.